Moreover, we demonstrated that Cdc42, which binds to a variety of effector proteins to regulate actin cytoskeleton remodelling and epithelial cell polarization, was strongly involved in SKA1‐induced PDAC progression, and inhibition of Cdc42 may represents a promising strategy for precise cancer therapy.46, 47, 48. The gene discussed is SKA1; the disease is cancer.